港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

1,308.644

+15.1701.17%

涨家数：9

跌家数：2

平家数：2

市盈率：- -

高：1,314.756

开：1,294.988

低：1,282.421

收：1,293.473

成交量：1.02亿

成交额：13.06亿

市值：2,178.87亿

流通市值：1,582.36亿

数据加载中...

每日卖空追踪 | 三生制药 09月29日卖空量成交87.45万股，卖空比例为4%

康哲药业09月29日主力净流出810.4万元散户资金买入

三生制药09月29日主力净流入4266.6万元散户资金抛售

昊海生物科技09月29日获主力加仓152.6万元

豫园股份股东浙江复星质押4000万股

复星医药卖资产保利润，创新转型持续推进

广西设100亿元人工智能产业基金；维信诺参设8.18亿元基金，债转股投控股公司 | 09.22-09.28

大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权

交银国际：特朗普加征药品关税对中国医药影响有限建议重点关注康方生物(09926)等

瑞丽医美盘中异动早盘股价大跌6.61%

多家药企公布创新药研发III期临床进展，涉及荨麻疹、肿瘤、减重等

复星医药拟12.6亿卖资产加码创新药发力科创三年半研发投入199.6亿

智通港股早知道 | 八部门发文推动有色金属行业稳增长香港将建全球固定收益及货币产品枢纽

复星医药核药总部项目落地成都天府国际生物城

每日经济新闻

港股公告掘金 | 名创优品建议分拆TOP TOY并于香港联交所主板独立上市

China Medical System Holdings Limited旗下MG-K10药物获得慢性自发性荨麻疹适应症III期临床试验批准

康哲药业(00867)：1类新药MG-K10人源化单抗注射液新增获得慢性自发性荨麻疹适应症药物III期临床试验批准通知书

前复星副总裁创办，AI制药融资上亿！

四环医药(00460.HK)购回150万股总价222万元

阿斯达克财经

康哲药业(867.HK; 8a8.SG)创新药芦可替尼乳膏特应性皮炎适应症中国三期临床试验获得积极结果

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1593/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1308.6436,"timestamp":1759219682091,"preClose":1293.4733,"halted":0,"volume":101712892,"delay":0,"changeRate":0.011728,"floatShares":0,"shares":0,"eps":0,"marketStatus":"国庆日休市","change":15.170288,"latestTime":"09-30 16:00:00","open":1294.9884,"high":1314.7557,"low":1282.4209,"amount":1306486169,"amplitude":0.024998,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759368600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1759195800000,1759204800000],[1759208400000,1759219200000]],"pbRate":1.904861,"peRate":26.7728,"turnoverRate":0.004924,"increases":8,"decrements":3,"flats":2,"marketCap":217887394200,"floatMarketCap":158236398872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1314.7557,"amplitude":0.024998,"preClose":1293.4733,"low":1282.4209,"pbRate":"1.904861","latestPrice":1308.6436,"volume":101712892,"delay":0,"open":1294.9884,"prevYearClose":571.87146,"prevWeekClose":1276.55,"prevMonthClose":1308.644,"prevQuarterClose":1308.644,"fiveDayClose":1356.006,"twentyDayClose":1314.432,"sixtyDayClose":1056.714,"secType":"PLATE","market":"HK","turnoverRate":0.004924,"peRate":26.7728,"marketCap":217887394200,"floatMarketCap":158236398872,"timestamp":1759219682091,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":9,"down":2,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571357266","title":"每日卖空追踪 | 三生制药 09月29日卖空量成交87.45万股，卖空比例为4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571357266","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571357266?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:30","pubTimestamp":1759134623,"startTime":"0","endTime":"0","summary":"三生制药北京时间09月29日，涨3.65%，卖空量成交87.45万股，较上一交易日减少84.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163241a44be351&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929163241a44be351&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1593","BK1583"],"gpt_icon":0},{"id":"2571361232","title":"康哲药业09月29日主力净流出810.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2571361232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571361232?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:15","pubTimestamp":1759133755,"startTime":"0","endTime":"0","summary":"09月29日, 康哲药业股价跌3.44%，报收13.75元，成交金额1.1亿元，换手率0.34%，振幅5.90%，量比1.23。康哲药业今日主力资金净流出810.4万元，上一交易日主力净流入94.5万元。该股近5个交易日下跌8.23%，主力资金累计净流出923.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3540.1万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929162211a44bdcb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929162211a44bdcb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","SG9999015986.USD","BK1191","LU2488822045.USD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","IE00BVYPNQ40.USD","SG9999004220.SGD","SG9999015952.SGD","00867","BK1593","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2571572503","title":"三生制药09月29日主力净流入4266.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2571572503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571572503?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:15","pubTimestamp":1759133739,"startTime":"0","endTime":"0","summary":"09月29日, 三生制药股价涨3.65%，报收30.14元，成交金额6.7亿元，换手率0.92%，振幅5.50%，量比0.79。三生制药今日主力资金净流入4266.6万元，上一交易日主力净流出4311.6万元。该股近5个交易日下跌2.52%，主力资金累计净流入2662.7万元；近20日主力资金累计净流入5.9亿元，其中净流入天数为10日。该股主力净额占比0.06%，港股市场排名175/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092916190797b080a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092916190797b080a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1593","01530"],"gpt_icon":0},{"id":"2571393386","title":"昊海生物科技09月29日获主力加仓152.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571393386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571393386?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 16:15","pubTimestamp":1759133713,"startTime":"0","endTime":"0","summary":"09月29日, 昊海生物科技股价涨1.08%，报收26.28元，成交金额797.0万元，换手率0.79%，振幅2.31%，量比0.89。昊海生物科技今日主力资金净流入152.6万元，连续3日净流入，上一交易日主力净流入9.4万元。该股近5个交易日下跌4.09%，主力资金累计净流入157.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出8.0万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929161556954bdbb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929161556954bdbb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1161","BK1593"],"gpt_icon":0},{"id":"2571358835","title":"豫园股份股东浙江复星质押4000万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2571358835","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571358835?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 15:52","pubTimestamp":1759132368,"startTime":"0","endTime":"0","summary":"9月29日，豫园股份（600655）发布公告，控股股东复星高科技旗下浙江复星将其持有的4000万股股份办理质押，占其所持股份的10.95%及公司总股本的1.03%。截至公告披露日，复星高科技及其一致行动人累计质押股份15.11亿股，占其所持股份的62.70%及公司总股本的38.82%。2025年中期，豫园股份实现收入191.12亿元，归母净利润6281万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929155325954bce79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929155325954bce79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1593","BK1515"],"gpt_icon":0},{"id":"2571133002","title":"复星医药卖资产保利润，创新转型持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2571133002","media":"览富财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571133002?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 14:54","pubTimestamp":1759128888,"startTime":"0","endTime":"0","summary":"复星医药在肿瘤、免疫炎症等核心治疗领域统治力似乎有所下降。财报显示，2025年上半年，复星医药整体营收195.14亿元，同比微降4.63%；归母净利润17.02亿元，同比增长38.96%，但扣非净利润 9.61亿元，同比下降23.39%。复星医药的产品销售情况也不乐观。整体来看，复星医药的研发体系协同性有待加强。目前，复星医药已在海","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092914551697b0550c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092914551697b0550c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02196","BK1593","BK1515"],"gpt_icon":0},{"id":"2571005330","title":"广西设100亿元人工智能产业基金；维信诺参设8.18亿元基金，债转股投控股公司 | 09.22-09.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2571005330","media":"创业邦","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571005330?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 14:40","pubTimestamp":1759128015,"startTime":"0","endTime":"0","summary":"01政府引导基金广西设100亿元人工智能产业基金9月23日，广西为落实国办及自治区部署，设立总规模100亿元的人工智能产业投资基金。湖北设立100亿元数据产业基金，首期20亿元赋能数字经济近日，湖北大数据创新发展大会在武汉举行，会上首次设立总规模100亿元的湖北数据产业基金，由湖北大数据集团联合相关机构发起。产业基金现公开征集子基金管理机构，要求实缴注册资本不低于1000万元人民币或等值货币资本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929144018a6a58e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929144018a6a58e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1515","BK1593","00564"],"gpt_icon":0},{"id":"2571800933","title":"大健康行业周报 |13亿，“中国美敦力”完成交割；东星医疗：拟以支付现金方式购买武汉医佳宝90%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2571800933","media":"保观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571800933?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 12:04","pubTimestamp":1759118650,"startTime":"0","endTime":"0","summary":"保观 |聚焦保险创新国内篇行业动态13亿，“中国美敦力”完成交割近日，上海生物医药并购基金携手浦东创投集团旗下引领区基金，完成收购日本大冢集团所持微创医疗股份的交割，交易金额达13亿元人民币，上海生物医药并购基金成为微创医疗重要战略股东，持股约7.3%。此次交割完成后，被视为“中国美敦力”的微创医疗股价在港股市场表现活跃，市值突破200亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929123929a44b6c21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03933","LU0326950275.SGD","BK1191","LU0588546209.SGD","LU0067412154.USD","LU1960683339.HKD","BK1500","LU1993786604.SGD","LU0315179316.USD","LU1328277881.USD","LU1719994722.HKD","LU1226287529.USD","LU1303224171.USD","IE00B543WZ88.USD","SG9999004220.SGD","BK1570","01276","03692","BK1197","LU1226287792.SGD","IE00B031HY20.USD","IE0008369823.USD","BK1515","LU0359201885.HKD","LU1251922891.USD","00874","IE0008368742.USD","00570","LU0072913022.USD","02196","01093","LU1008478684.HKD","LU2039709279.SGD","LU1023057109.AUD","LU1226288170.HKD","LU1226288253.USD","LU2543165471.USD","LU2328871848.SGD","LU1152091168.USD","LU1152091754.HKD","LU1226287875.USD","03320","06160","LU1969619763.USD","IE00B5MMRT66.SGD","01177","SBHMY","BK1606","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1593"],"gpt_icon":0},{"id":"2571705988","title":"交银国际：特朗普加征药品关税对中国医药影响有限 建议重点关注康方生物(09926)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571705988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571705988?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 11:37","pubTimestamp":1759117068,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，特朗普宣布10月起对所有品牌/专利药征收100%关税，除非该制造商正在美国境内兴建生产设施。交银国际认为，这对中国创新药产业链影响有限，无需过度担忧：1)创新药：当前自主出海品种多在美自建产能或已将生产外包给美国本土CMO，而大部分国产创新药出海采用BD模式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0010","BK1191","BK1583","LU0417516902.SGD","09995","LU2399975544.HKD","600056","LU2476274308.USD","LU0348767384.USD","BK1161","LU0348827113.USD","LU1794554557.SGD","LU1961090484.USD","IE00B543WZ88.USD","06996","09926","IE00BPRC5H50.USD","LU0417516738.SGD","BK1147","LU1720050803.USD","LU2476274720.SGD","LU0348783233.USD","BK0185","BK0082","06990","LU0348784397.USD","BK0028","BK0188","LU0417516571.SGD","LU2778985437.USD","LU2328871848.SGD","LU2488822045.USD","LU0348766576.USD","BK0175","LU0634319403.HKD","BK0250","LU0348735423.USD","03329","LU0196878994.USD","LU0348825331.USD","LU0561508036.HKD","LU0540923850.HKD","LU1969619763.USD","IE00B5MMRT66.SGD","02096","01530","BK1593","BK1574"],"gpt_icon":0},{"id":"2571538803","title":"瑞丽医美盘中异动 早盘股价大跌6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571538803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571538803?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 10:51","pubTimestamp":1759114274,"startTime":"0","endTime":"0","summary":"2025年09月29日早盘10时51分，瑞丽医美股票出现波动，股价快速下跌6.61%。截至发稿，该股报0.113港元/股，成交量1.6万股，换手率0.00%，振幅0.00%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体跌幅为0.09%。其相关个股中，万嘉集团、康健国际医疗、瑞尔集团涨幅较大，振幅较大的相关个股有万嘉集团、盈健医疗、金威医疗，振幅分别为12.50%、8.33%、7.14%。瑞丽医美公司简介：瑞丽医美国际控股有限公司是一家主要从事提供医疗美容服务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929105114a6a52a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929105114a6a52a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2571361239","title":"多家药企公布创新药研发III期临床进展，涉及荨麻疹、肿瘤、减重等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571361239","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571361239?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 10:24","pubTimestamp":1759112640,"startTime":"0","endTime":"0","summary":"近期，国内多家药企公布创新药研发III期临床进展，涉及多个治疗领域。康哲药业9月28日宣布，旗下德镁医药的1类新药抗IL-4Rα MG-K10人源化单抗注射液获NMPA批准，将开展用于慢性自发性荨麻疹的III期临床试验，MG-K10具有更长半衰期，有望成为全球首个长效抗IL-4Rα单抗。9月26日，第一三共宣布Ifinatamab Deruxtecan用于二线治疗晚期/转移性食管鳞癌的III期研究在中国完成首例受试者给药，该药是潜在首款靶向B7-H3的ADC。9月25日晚，维康药业公告称，“黄甲软肝颗粒”Ⅲ期临床试验项目启动会召开。这些进展将为荨麻疹、肿瘤等患者带来新的治疗希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929105611a44b3cf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929105611a44b3cf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BGHQDM52.EUR","BK1593","BK1574","06978","IE00BMCWC346.EUR","00867","IE00BVYPNQ40.USD","SG9999015986.USD","SG9999004220.SGD","LU2488822045.USD","SG9999015952.SGD","SG9999015978.USD","BK1161","IE00BYV24P56.USD","BK1191","SG9999015945.SGD","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2571588853","title":"复星医药拟12.6亿卖资产加码创新药 发力科创三年半研发投入199.6亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2571588853","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571588853?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 07:07","pubTimestamp":1759100861,"startTime":"0","endTime":"0","summary":"9月26日晚，复星医药发布公告，公司拟出资5460万元参与设立专项基金，基金成立后，公司拟将上海克隆100%股权作价12.56亿元转让给专项基金，而上海克隆的主要资产为物业。过去三年，复星医药的研发投入合计达173.76亿元。处置资产聚焦核心业务复星医药再度处置资产，加码创新药业务布局。公告显示，本次转让所得款项将用于复星医药创新药业务的持续投入。2025年以来，复星医药频频出售资产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929071911a44ad422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929071911a44ad422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","BK1574","06978","02196","BK1161","BK1191"],"gpt_icon":0},{"id":"2571820390","title":"智通港股早知道 | 八部门发文推动有色金属行业稳增长 香港将建全球固定收益及货币产品枢纽","url":"https://stock-news.laohu8.com/highlight/detail?id=2571820390","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571820390?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 06:35","pubTimestamp":1759098943,"startTime":"0","endTime":"0","summary":"上周道指累计下跌0.15%，标普500指数下跌0.31%，纳斯达克综合指数下跌0.65%。香港财政司司长：香港将建全球固定收益及货币产品枢纽香港特区政府财政司司长陈茂波 28 日发表网志指出，香港正全力推进固定收益及货币市场发展，目标是建设成为全球重要的固定收益及货币产品枢纽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0880133367.SGD","00874","LU1152091754.HKD","LU2148510915.USD","LU1226288253.USD","BK1521","HK0000500386.USD","159871","IE00BYV24P56.USD","LU0164865239.USD","80883","LU0531971595.HKD","IE00BVYPNP33.GBP","LU1064131003.USD","BK4614","HSCEI","SG9999015945.SGD","BK1536","BK1506","LU1481107354.HKD","00941","LU1064130708.USD","YANG","LU1226288170.HKD","00340","IE00BGHQDM52.EUR","LU1226287792.SGD","SG9999015986.USD","LU1226287875.USD","00867","000819.SH","BK1197","BK1544","BK1589","165316","LU0164880469.USD","LU1152091168.USD","LU1497733631.SGD","BK1515","SG9999002463.SGD","HSTECH","HK0000252152.HKD","BK1593","SG9999004220.SGD","LU0067412154.USD","LU0149721374.USD","LU1008478684.HKD","LU0039217434.USD","BK1610"],"gpt_icon":1},{"id":"2571082615","title":"复星医药核药总部项目落地成都天府国际生物城","url":"https://stock-news.laohu8.com/highlight/detail?id=2571082615","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571082615?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 22:23","pubTimestamp":1759069391,"startTime":"0","endTime":"0","summary":"成都天府国际生物城相关负责人表示，此次核药项目的落户将进一步增强区域核医疗产业链的完整性与竞争力，助力打造全球领先的诊疗一体化核药中试与生产基地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928222557a6a442b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928222557a6a442b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1593","02196","BK1191"],"gpt_icon":0},{"id":"2570484447","title":"港股公告掘金 | 名创优品建议分拆TOP TOY并于香港联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2570484447","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570484447?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 20:00","pubTimestamp":1759060801,"startTime":"0","endTime":"0","summary":"重大事项：长风药业(02652)9月26日-10月2日招股 拟全球发售4119.8万股H股同仁堂国药(03613)获发《传统药品注册许可证》康哲药业(00867)：创新药磷酸芦可替尼乳膏AD适应症中国三期药物临床研究取得积极结果沛嘉医疗-B(09996)：ReachTactile机器人辅助TAVR系统多中心注册临床试验的首例患者治疗名创优品(09896)建议分拆TOP TOY并于香港联交所主板独立","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00874","BK4614","BK1197","LU1046422090.SGD","BK4588","BK1593","BK1249","BK1530","00564","02380","HSCEI","00123","MNSO","BK4585","BK1191","09896","BK1606","BK4114","02196","BK4220","HSTECH","BK4505","BK1171","YANG","BK1125","BK1246","BK1240","LU0274383008.USD","BK1515","BK1521","BK1555"],"gpt_icon":1},{"id":"1118997783","title":"China Medical System Holdings Limited旗下MG-K10药物获得慢性自发性荨麻疹适应症III期临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1118997783","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118997783?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 19:57","pubTimestamp":1759060638,"startTime":"0","endTime":"0","summary":"China Medical System Holdings Limited宣布，其MG-K10药物针对慢性自发性荨麻疹适应症的III期临床试验已获得批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1593","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015986.USD","IE00BYV24P56.USD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015978.USD","00867","SG9999015945.SGD","BK1191","SG9999004220.SGD","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2570844305","title":"康哲药业(00867)：1类新药MG-K10人源化单抗注射液新增获得慢性自发性荨麻疹适应症药物III期临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2570844305","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570844305?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 19:51","pubTimestamp":1759060312,"startTime":"0","endTime":"0","summary":"产品的嗜酸性粒细胞性食管炎、慢性鼻窦炎伴鼻息肉适应症也已获得NMPA签发的药物临床试验批准通知书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","IE00BVYPNQ40.USD","III","LU2488822045.USD","MG","IE00B7SZL793.SGD","IE00BYV24P56.USD","00867","BK4134","IE0031619046.USD","IE00B19Z4B17.USD","IE00BVYPNP33.GBP","SG9999004220.SGD","BK1593","SG9999015952.SGD","IE00B66KJ199.SGD","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015978.USD","SG9999015945.SGD","BK4123","SG9999015986.USD"],"gpt_icon":0},{"id":"2571163826","title":"前复星副总裁创办，AI制药融资上亿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2571163826","media":"智药局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571163826?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 18:31","pubTimestamp":1759055483,"startTime":"0","endTime":"0","summary":"近日，弘星相和(太仓)生物科技有限公司宣布完成近亿元人民币Pre-A轮融资。弘星相和成立于2021年，专注于生物医药前沿技术产品创新研发。创始人邵颖拥有超过35年的医药行业经验，并在监管和上市药企担任重要职务。他推动复星医药从传统仿制药企业向创新驱动的国际化药企转型，奠定了其在生物药、创新小分子等领域的布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928211356a44a2f0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928211356a44a2f0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1574","BK1191","BK1593","BK1515","02196"],"gpt_icon":0},{"id":"2570459928","title":"四环医药(00460.HK)购回150万股  总价222万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570459928","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570459928?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 16:37","pubTimestamp":1759048620,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK) 公布，9月26日，于市场购回总共150万股，每股平均价1.48元，总购买价222万元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-09-26 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220413154448549_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220413154448549_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1473370/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK1600","BK1191","BK1593","00460"],"gpt_icon":0},{"id":"1180109825","title":"康哲药业(867.HK; 8a8.SG)创新药芦可替尼乳膏特应性皮炎适应症中国三期临床试验获得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180109825","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180109825?lang=zh_cn&edition=fundamental","pubTime":"2025-09-28 12:24","pubTimestamp":1759033469,"startTime":"0","endTime":"0","summary":"康哲药业(867.HK; 8a8.SG)创新药芦可替尼乳膏特应性皮炎适应症中国三期临床试验获得积极结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYV24P56.USD","BK1593","SG9999015986.USD","SG9999015945.SGD","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","LU2488822045.USD","00867","SG9999004220.SGD","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BMCWC346.EUR","BK1191","SG9999015978.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":141,"code":"91000000","status":"200"}]}}